Advertisement
Advertisement

CSBR

CSBR logo

Champions Oncology, Inc.

6.14
USD
Sponsored
-0.09
-1.44%
Jun 24, 15:59 UTC -4
Closed
exchange

After-Market

6.45

+0.31
+4.97%

CSBR Earnings Reports

Positive Surprise Ratio

CSBR beat 17 of 32 last estimates.

53%

Next Report

Date of Next Report
Jul 16, 2026
Estimate for Q4 26 (Revenue/ EPS)
$13.14M
/
-$0.05
Implied change from Q3 26 (Revenue/ EPS)
-20.63%
/
+150.00%
Implied change from Q4 25 (Revenue/ EPS)
+6.38%
/
-28.57%

Champions Oncology, Inc. earnings per share and revenue

On Mar 12, 2026, CSBR reported earnings of -0.02 USD per share (EPS) for Q3 26, missing the estimate of 0.09 USD, resulting in a -121.79% surprise. Revenue reached 16.56 million, compared to an expected 16.95 million, with a -2.27% difference. The market reacted with a +6.27% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 3 analysts forecast an EPS of -0.05 USD, with revenue projected to reach 13.14 million USD, implying an increase of 150.00% EPS, and decrease of -20.63% in Revenue from the last quarter.
FAQ
For Q3 2026, Champions Oncology, Inc. reported EPS of -$0.02, missing estimates by -121.79%, and revenue of $16.56M, -2.27% below expectations.
The stock price moved up 6.27%, changed from $5.74 before the earnings release to $6.10 the day after.
The next earning report is scheduled for Jul 16, 2026.
Based on 3 analysts, Champions Oncology, Inc. is expected to report EPS of -$0.05 and revenue of $13.14M for Q4 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement